OptumRx Inc., a notable pharmacy benefit manager implicated in the opioid crisis, has recently made a move to disqualify the plaintiffs’ firm, Motley Rice. The pharmacy benefit manager’s representative, Alston & Bird’s Brian Boone, cites alleged ethical violations tied to confidential information that the plaintiff firm obtained through government subpoenas as the reason for this motion.
Motley Rice in its capacity as outside counsel represents the state of Hawaii, the city of Chicago, and the attorney general of the District of Columbia – all entities either investigating or raising lawsuits against OptumRx, a healthcare company owned by United HealthCare. The firm’s alleged ethical violations may influence their involvement in these cases.
More comprehensive details on the allegations and the potential implications for the ongoing cases are further explored in the original Law.com report.